• Name
      Christopher G. Bell
    • Qualifications
      MB ChB, PhD, FRCPA
    • Role
      Lecturer in Epigenomics

    Christopher Bell gained his medical degree from University of Otago, New Zealand, and he is a registered medical consultant in Pathology, subspecialty Genetics, with the Australian Health Practitioner Regulation Agency (AHPRA).

    His research career has focused on the genomics and epigenomics of human diseases, principally Type II Diabetes and Obesity. He gained his Ph.D. in Genomics from Imperial College, London, under the guidance of Prof. Philippe Froguel. His post-doctoral Epigenomics experience was with Prof. Stephan Beck at UCL Cancer Institute, University College London.

    Within the area of Epigenomic Medicine, his research uses computational biology, statistical genetics, and bioinformatics to further understand common human diseases. This work involves the integration of large-scale epigenomic analyses in population, comparative and multi-omic datasets. He has published widely in the field of Epigenetics, Genomic Medicine, and Pathology, with a broad network of worldwide collaborators. Furthermore, he has contributed key innovations to the integration of GWAS and Epigenetic data, as well as evolutionary analytical approaches to this fast advancing field.